Processing, please wait...


Plastic Surgeon

Dr. Friedman graduated from Rapaport school of medicine at the Technion Institute of Technology and the plastic reconstructive surgery residency program of the Tel Aviv Medical Center. 

Dr. friedman was awarded the first Kahn foundation grant for outstanding research physicians. Supported by the fund Dr. Friedman developed the basic plastic surgery lab, now at the forefront of the field's research in the world. 

Dr. Friedman is a member of the American Society of Plastic Surgeons, The American Society of Reconstructive Microsurgery, and International Confederation of Plastic Surgery Societies.  Dr. Friedman serves on various professional committees and as an associate editor of the PRS global open journal. 

read more
add item add Or FRIEDMAN

Or FRIEDMAN's publications (19)

Retrospective photographic review of nontattoo indications treated by picosecond laser.

Mar, 2020

Picosecond (PS) lasers were approved by the US FDA in 2012 after being shown to remove tattoos with more success and fewer treatments compared with traditional methods. PS lasers were shown to be versatile, indicated for the treatment of lentigines, café-au-lait macules (CALMs), and acne scars and skin rejuvenation. read more

Journal of cosmetic dermatology

Intense focused ultrasound for neck and lower face skin tightening a prospective study.

Apr, 2020

Intense focused ultrasound (IFUS) is a Nonablative skin tightening technology with good safety profile, but limited efficacy. Most clinical studies have been performed to evaluate the efficacy of the Ulthera IFUS (Ulthera, Mesa, AZ) in treating redundant skin. read more

Journal of cosmetic dermatology

Treatment of port wine stain with Tixel-induced rapamycin delivery following pulsed dye laser application.

01, 2020

Although pulsed dye laser (PDL) is considered the gold standard treatment for port wine stains (PWS), post PDL revascularization is one of the main causes of incomplete regression and recurrence. Recently, topical sirolimus have been shown to improve treatment outcome probably through minimizing post-laser revascularization. We sought to evaluate the added value of the Tixel drug delivery system (DDS) to the PDL and topical rapamycin treatment for PWS. This case series includes three teenager patients with previously treated PWS with PDL. Upon enrollment, every stain was divided into A and B halves for treatment assignments to the following regimens: (A) PDL + DDS + rapamycin; (B) PDL + rapamycin. Subjects were instructed to apply rapamycin topically over the PWS twice daily for the entire treatment period. Assessment of the treatment and adverse reactions as well as photographs was performed at baseline and before every PDL treatment. There were clinically significant differences in blanching responses favoring PWS receiving PDL + DDS + rapamycin as compared to PDL + rapamycin alone. Transient hyperpigmentation was noted in one patient. Two patients developed mild transient irritation and dermatitis following the treatment on both halves. The use of drug delivery system combined with topical rapamycin has no remarkable adverse effects, improves the results of PDL treatment for port wine stains, and can reduce the total number of required PDL sessions. read more

Dermatologic therapy
Load more  

Or FRIEDMAN's connections (1)

Or FRIEDMAN's scientific societies (3)

IPRAS International Confederation for Plastic Reconstructive and Aesthetic Surgery